Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy

ANZ Journal of Surgery

Volumn 83, Issue 7-8, 2013, Pages 527-532

  Musiello, Toni ^a   Bornhammar, Emelie ^b   Saunders, Christobel ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Attitudes; Breast cancer; Breast surgery; Contralateral prophylactic mastectomy; Surgeons

Indexed keywords

ADULT; ARTICLE; ATTITUDES; AUSTRALIA; BREAST CANCER; BREAST SURGERY; BREAST TUMOR; CLINICAL COMPETENCE; CLINICAL PRACTICE; CONTRALATERAL PROPHYLACTIC MASTECTOMY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MASTECTOMY; MIDDLE AGED; NEW ZEALAND; PATIENT SELECTION; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SURGEONS; UTILIZATION REVIEW;

ATTITUDES; BREAST CANCER; BREAST SURGERY; CONTRALATERAL PROPHYLACTIC MASTECTOMY; SURGEONS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; BREAST NEOPLASMS; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASTECTOMY; MIDDLE AGED; NEW ZEALAND; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES;

EID: 84881022997     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2012.06209.x     Document Type: Article

References (26)

1. Saunders CM, Sunil J. Breast Cancer, 1st edn. New York: Oxford University Press, 2009.
2. Jones N, Wilson J, Kotur L, Stephens J, Farrar W, Agnese D. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann. Surg. Oncol. 2009; 16: 2691-2696.
3. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J. Clin. Oncol. 2007; 25: 5203-5209.
4. Yao K, Stewart A, Winchester D. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the national cancer data base, 1998-2007. Ann. Surg. Oncol. 2010; 17: 2554-2562.
5. King TA, Sakr R, Patil S etal. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J. Clin. Oncol. 2011; 29: 2158-2164.
6. Montgomery LL, Tran KN, Heelan MC etal. Issues of regret in women with contralateral prophylactic mastectomies. Ann. Surg. Oncol. 1999; 6: 546-552.
7. Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann. Surg. Oncol. 2009; 16: 2697-2704.
8. Wood WC. Should the use of contralateral prophylactic mastectomy be increasing as it is? Breast 2009; 18 (Suppl. 3): S93-95. doi: 10.1016/S0960-9776(09)70282-6.
9. Wood WC, Whitehead JB. Increasing use of contralateral prophylactic mastectomy: a counterintuitive trend. Oncology (Huntingt) 2008; 22: 548-1.
10. Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann. Surg. Oncol. [Clinical Trial]. 2009; 16: 2691-2696.
11. Metcalfe K, Lynch HT, Ghadirian P etal. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J. Clin. Oncol. 2004; 22: 2328-2335.
12. Blackwood M, Weber B. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J. Clin. Oncol. 1998; 16: 1969-1977.
13. Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am. J. Surg. 2000; 180: 439-445.
14. Herrinton LJ, Barlow WE, Yu O etal. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J. Clin. Oncol. [Evaluation Studies]. 2005; 23: 4275-4286.
15. Bedrosian I, Hu C-Y, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J. Natl. Cancer Inst. 2010; 102: 401-409.
16. Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br. J. Cancer 1984; 49: 79-85.
17. Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur. J. Surg. Oncol. 1999; 25: 584-589.
18. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst. Rev. [Meta-Analysis Review]. 2010; 11: CD002748.
19. Ford D, Easton DF, Stratton M etal. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1998; 62: 676-689.
20. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 855-861.
21. Hulka BS, Moorman PG. Reprint of Breast cancer: hormones and other risk factors. Maturitas 2008; 61: 203-213.
22. Claus EB, Stowe M, Carter D, Holford T. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 2003; 12: 451-456.
23. Arpino G, Bardou V, Clark G, Elledge R. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004; 6: R149-156.
24. Dunn BK, Ford LG. Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT). Eur. J. Cancer 2000; 36 (Suppl. 4): 49-50.
25. Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann. Surg. Oncol. 2011; 18: 3129-3136.
26. Surgeons RACo. National Breast Cancer Audit. Melbourne: Royal Australasian College of Surgeons; [updated 5 September 2011; Cited 25 Nov 2011.] Available from URL: http://www.surgeons.org/racs/research-and-audit/morbidity-audits/national-breast-cancer-audit